MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1 Retraction in /10.3892/ol.2021.12905

Zheng,Keyan; Liu,Weicheng; Liu,Ye; Jiang,Congqing; Qian,Qun

doi:10.3892/ol.2014.2753

MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1

Retraction in 10.3892/ol.2021.12905

Authors:
- Keyan Zheng
- Weicheng Liu
- Ye Liu
- Congqing Jiang
- Qun Qian
View Affiliations

Affiliations: Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China
Published online on: December 1, 2014 https://doi.org/10.3892/ol.2014.2753
Pages: 869-874

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRs) are a type of small non‑coding RNA molecule that are involved in gene silencing and the regulation of cancer progression; miR‑133a in particular has been implicated in colorectal cancer, although its specific role and underlying mechanism have yet to be determined. In the present study, the expression level of miR‑133a was significantly downregulated in a number of colorectal cancer cell lines, as well as in colorectal cancer tissues compared with the normal adjacent tissues. Furthermore, the Fascin1 (FSCN1) gene was identified as a direct target of miR‑133a, and the protein expression level of FSCN1 was negatively regulated by miR‑133a in colorectal cancer cells. Additionally, restoration of miR‑133a expression and downregulation of FSCN1 protein expression suppressed colorectal cancer cell invasion, while overexpression of FSCN1 reversed the inhibitory effect of miR‑133a upregulation on colorectal cancer cell invasion. Thus, the present data indicates that miR‑133a may at least partially suppress colorectal cancer cell invasion, possibly via the inhibition of FSCN1 expression. The present study highlights the important role of miR‑133a in the progression of colorectal cancer.

View Figures

View References

1	Siegel R, Desantis C and Jemal A: Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117. 2014. View Article : Google Scholar : PubMed/NCBI
2	Hammoud SS, Cairns BR and Jones DA: Epigenetic regulation of colon cancer and intestinal stem cells. Curr Opin Cell Biol. 25:177–183. 2013. View Article : Google Scholar : PubMed/NCBI
3	Okayama H, Schetter AJ and Harris CC: MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Dig Dis. 30(Suppl 2): 9–15. 2012. View Article : Google Scholar : PubMed/NCBI
4	Khare S and Verma M: Epigenetics of colon cancer. Methods Mol Biol. 863:177–185. 2012. View Article : Google Scholar : PubMed/NCBI
5	Qian B, Nag SA, Su Y, et al: miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents. Curr Cancer Drug Targets. 13:519–541. 2013. View Article : Google Scholar : PubMed/NCBI
6	Fabbri M, Calore F, Paone A, Galli R and Calin GA: Epigenetic regulation of miRNAs in cancer. Adv Exp Med Biol. 754:137–148. 2013. View Article : Google Scholar
7	Wang LK, Hsiao TH, Hong TM, et al: MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma. PLoS One. 9:e967652014. View Article : Google Scholar : PubMed/NCBI
8	Qiu T, Zhou X, Wang J, et al: MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Lett. 588:1168–1177. 2014. View Article : Google Scholar : PubMed/NCBI
9	Fujiwara T, Katsuda T, Hagiwara K, et al: Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. Stem Cells. 32:959–973. 2014. View Article : Google Scholar : PubMed/NCBI
10	Akanuma N, Hoshino I, Akutsu Y, et al: MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer. 110:189–198. 2014. View Article : Google Scholar :
11	Guo J, Xia B, Meng F and Lou G: miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor. Tumour Biol. 35:1557–1564. 2014. View Article : Google Scholar
12	Wang H, An H, Wang B, et al: miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Eur J Cancer. 49:3924–3935. 2013. View Article : Google Scholar : PubMed/NCBI
13	Park SH, Song JY, Kim YK, et al: Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells. Int J Oncol. 44:637–646. 2014.PubMed/NCBI
14	Yamakita Y, Matsumura F, Lipscomb MW, et al: Fascin1 promotes cell migration of mature dendritic cells. J Immunol. 186:2850–2859. 2011. View Article : Google Scholar : PubMed/NCBI
15	Chen MB, Wei MX, Han JY, et al: MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer. Cell Signal. 26:102–109. 2014. View Article : Google Scholar
16	Tsai WC, Chao YC, Sheu LF, Chang JL, Nieh S and Jin JS: Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers. 23:153–160. 2007. View Article : Google Scholar : PubMed/NCBI
17	Ye JJ and Cao J: MicroRNAs in colorectal cancer as markers and targets: Recent advances. World J Gastroenterol. 20:4288–4299. 2014. View Article : Google Scholar : PubMed/NCBI
18	Wu ZS, Wang CQ, Xiang R, et al: Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer. 12:512012. View Article : Google Scholar : PubMed/NCBI
19	Arndt GM, Dossey L, Cullen LM, et al: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer. 9:3742009. View Article : Google Scholar : PubMed/NCBI
20	Sarver AL, French AJ, Borralho PM, et al: Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer. 9:4012009. View Article : Google Scholar : PubMed/NCBI
21	Dong Y, Zhao J, Wu CW, et al: Tumor suppressor functions of miR-133a in colorectal cancer. Mol Cancer Res. 11:1051–1060. 2013. View Article : Google Scholar : PubMed/NCBI
22	Wen YH, Yee H, Goswami S and Shukla PS: Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy. Int J Gynecol Pathol. 28:187–192. 2009. View Article : Google Scholar : PubMed/NCBI
23	Fu H, Hu Z, Wen J, Wang K and Liu Y: TGF-β promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. Acta Biochim Biophys Sin (Shanghai). 41:648–656. 2009. View Article : Google Scholar
24	Chan C, Jankova L, Fung CL, et al: Fascin expression predicts survival after potentially curative resection of node-positive colon cancer. Am J Surg Pathol. 34:656–666. 2010.PubMed/NCBI
25	Machesky LM and Li A: Fascin: Invasive filopodia promoting metastasis. Commun Integr Biol. 3:263–270. 2010. View Article : Google Scholar : PubMed/NCBI
26	Chiyomaru T, Enokida H, Tatarano S, et al: miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer. 102:883–891. 2010. View Article : Google Scholar : PubMed/NCBI
27	Kano M, Seki N, Kikkawa N, et al: miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer. 127:2804–2814. 2010. View Article : Google Scholar